{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:40:14Z","timestamp":1788302414932,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI081239, PI09\/90609,PI19\/01006"],"award-info":[{"award-number":["PI081239, PI09\/90609,PI19\/01006"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The European Regional Development Fund"},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study sought to assess the effectiveness and return on investment (ROI) of a multifaceted intervention aimed at improving antibiotic prescribing for acute respiratory infections in primary care.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design<\/jats:title>\n                <jats:p>Large-sized, two-arm, open-label, pragmatic, cluster-randomised controlled trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Setting<\/jats:title>\n                <jats:p>All primary care physicians working for the Spanish National Health Service (NHS) in Galicia (region in north-west Spain).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Participants<\/jats:title>\n                <jats:p>The seven spatial clusters were distributed by unequal randomisation (3:4) of the intervention and control groups. A total of 1217 physicians (1.30 million patients) were recruited from intervention clusters and 1393 physicians (1.46 million patients) from control clusters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Interventions<\/jats:title>\n                <jats:p>One-hour educational outreach visits tailored to training needs identified in a previous study; an online course integrated in practice accreditation; and a clinical decision support system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main outcome measures<\/jats:title>\n                <jats:p>Changes in the ESAC (European Surveillance of Antimicrobial Consumption) quality indicators for outpatient antibiotic use. We used generalised linear mixed and conducted a ROI analysis to ascertain the overall cost savings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median follow-up was 19\u2009months. The adjusted effect on overall antibiotic prescribing attributable to the intervention was \u2212\u20094.2% (95% CI: \u2212\u20095.3% to \u2212\u20093.2%), with this being more pronounced for penicillins \u2212\u20096.5 (95% CI: \u2212\u20097.9% to \u2212\u20095.2%) and for the ratio of consumption of broad- to narrow-spectrum penicillins, cephalosporins, and macrolides \u2212\u20099.0% (95% CI: \u2212\u200914.0 to \u2212\u20094.1%). The cost of the intervention was \u20ac87 per physician. Direct savings per physician attributable to the reduction in antibiotic prescriptions was \u20ac311 for the NHS and \u20ac573 for patient contributions, with an ROI of \u20ac2.57 and \u20ac5.59 respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Interventions designed on the basis of gaps in physicians\u2019 knowledge of and attitudes to misprescription can improve antibiotic prescribing and yield important direct cost savings.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: Current Controlled Trials <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN24158380\">ISRCTN24158380<\/jats:ext-link>. Registered 5 February 2009.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-020-00857-9","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T13:07:49Z","timestamp":1607346469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of a multifaceted intervention to improve antibiotic prescribing: a pragmatic cluster-randomised controlled trial"],"prefix":"10.1186","volume":"9","author":[{"name":"on behalf of the GREPHEPI Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Figueiras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"L\u00f3pez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Gonzalez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"V\u00e1zquez-Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"L\u00f3pez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coro","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Herdeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maruxa","family":"Zapata-Cachafeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"857_CR1","volume-title":"Global action plan on antimicrobial resistance","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. Genoa: World Health Organization; 2015."},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","volume":"14","author":"TP Van Boeckel","year":"2014","unstructured":"Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742\u201350.","journal-title":"Lancet Infect Dis"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s11606-012-2267-2","volume":"28","author":"CB Litvin","year":"2013","unstructured":"Litvin CB, Ornstein SM, Wessell AM, Nemeth LS, Nietert PJ. Use of an electronic health record clinical decision support tool to improve antibiotic prescribing for acute respiratory infections: the ABX-TRIP study. J Gen Intern Med. 2013;28:810\u20136.","journal-title":"J Gen Intern Med"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dks445","volume":"68","author":"KJ Suda","year":"2013","unstructured":"Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother. 2013;68:715\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR6","volume-title":"Summary of the latest data on antibiotic consumption in EU","author":"European Centre for Disease Prevention and Control","year":"2016","unstructured":"European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in EU: 2016. https:\/\/ecdc.europa.eu\/en\/publications-data\/summary-latest-data-antibiotic-consumption-eu-2016 Accessed 05 Apr 2020."},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(11)70054-8","volume":"11","author":"DJ Morgan","year":"2011","unstructured":"Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11:692\u2013701.","journal-title":"Lancet Infect Dis"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0212-6567(02)79085-9","volume":"30","author":"A Alvarez Carrera","year":"2002","unstructured":"Alvarez Carrera A, Mart\u00ednez Cantarero C, Vidal Oliveras A, Saavedra V\u00edlchez MD, Iglesias Niubo A, Forga VX. Antibiotics prescription in ambulatory patient. Aten Primaria. 2002;30:490\u20135.","journal-title":"Aten Primaria"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","volume":"315","author":"KE Fleming-Dutra","year":"2016","unstructured":"Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315:1864\u201373.","journal-title":"JAMA"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/bmj.39345.405243.BE","volume":"335","author":"I Petersen","year":"2007","unstructured":"Petersen I, Johnson AM, Islam A, Duckworth G, Livermore DM, Hayward AC. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK general practice research database. BMJ. 2007;335:982.","journal-title":"BMJ"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1071\/HI13019","volume":"18","author":"R Hardy-Holbrook","year":"2013","unstructured":"Hardy-Holbrook R, Aristidi S, Chandnani V, DeWindt D, Dinh K. Antibiotic resistance and prescribing in Australia: current attitudes and practice of GPs. Healthcare Infection. 2013;18:147\u201351.","journal-title":"Healthcare Infection"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/fampra\/cmr084","volume":"29","author":"JM Vazquez-Lago","year":"2012","unstructured":"Vazquez-Lago JM, Lopez-Vazquez P, L\u00f3pez-Dur\u00e1n A, Taracido-Trunk M, Figueiras A. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. Fam Pract. 2012;29:352\u201360.","journal-title":"Fam Pract"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1093\/jac\/dkw238","volume":"71","author":"P L\u00f3pez-V\u00e1zquez","year":"2016","unstructured":"L\u00f3pez-V\u00e1zquez P, V\u00e1zquez-Lago JM, Gonzalez-Gonzalez C, Pi\u00f1eiro-Lamas M, L\u00f3pez-Dur\u00e1n A, Herdeiro MT, et al. Development and validation of the knowledge and attitudes regarding antibiotics and resistance (KAAR-11) questionnaire for primary care physicians. J Antimicrob Chemother. 2016;71:2972\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR14","doi-asserted-by":"publisher","first-page":"e0141820","DOI":"10.1371\/journal.pone.0141820","volume":"10","author":"C Gonzalez-Gonzalez","year":"2015","unstructured":"Gonzalez-Gonzalez C, L\u00f3pez-V\u00e1zquez P, V\u00e1zquez-Lago JM, Pi\u00f1eiro-Lamas M, Herdeiro MT, Arzamendi PC, et al. Effect of Physicians\u2019 attitudes and knowledge on the quality of antibiotic prescription: a cohort study. PLoS One. 2015;10:e0141820.","journal-title":"PLoS One"},{"issue":"9","key":"857_CR15","first-page":"CD012252","volume":"9","author":"SK Tonkin-Crine","year":"2017","unstructured":"Tonkin-Crine SK, Tan PS, van Hecke O, Wang K, Roberts NW, McCullough A, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017;9(9):CD012252.","journal-title":"Cochrane Database Syst Rev"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1186\/1471-2458-14-1276","volume":"14","author":"F Roque","year":"2014","unstructured":"Roque F, Herdeiro MT, Soares S, Teixeira Rodrigues A, Breitenfeld L, Figueiras A. Educational interventions to improve prescription and dispensing of antibiotics: a systematic review. BMC Public Health. 2014;14:1276.","journal-title":"BMC Public Health"},{"key":"857_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/jamainternmed.2013.1984","volume":"173","author":"JA Linder","year":"2013","unstructured":"Linder JA. Antibiotic prescribing for acute respiratory infections\u2014success That\u2019s way off the mark comment on \u201ca cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis\u201d. JAMA Intern Med. 2013;173:273\u20135.","journal-title":"JAMA Intern Med"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/jech-2016-208141","volume":"71","author":"R Masters","year":"2017","unstructured":"Masters R, Anwar E, Collins B, Cookson R, Capewell S. Return on investment of public health interventions: a systematic review. J Epidemiol Community Health. 2017;71:827\u201334.","journal-title":"J Epidemiol Community Health"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"d8173","DOI":"10.1136\/bmj.d8173","volume":"344","author":"CC Butler","year":"2012","unstructured":"Butler CC, Simpson SA, Dunstan F, Rollnick S, Cohen D, Gillespie D, et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ. 2012;344:d8173.","journal-title":"BMJ"},{"issue":"4","key":"857_CR20","first-page":"CD003539","volume":"2005","author":"ArnoldSR, StrausSE","year":"2005","unstructured":"ArnoldSR, StrausSE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;2005(4):CD003539.","journal-title":"Cochrane Database Syst Rev"},{"key":"857_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1136\/bmj.303.6814.1385","volume":"303","author":"M Simpson","year":"1991","unstructured":"Simpson M, Buckman R, Stewart M, Maguire P, Lipkin M, Novack D, et al. Doctor-patient communication: the Toronto consensus statement. BMJ. 1991;303:1385\u20137.","journal-title":"BMJ"},{"key":"857_CR22","doi-asserted-by":"crossref","unstructured":"Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2007; (3): CD004417.","DOI":"10.1002\/14651858.CD004417.pub3"},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jama.296.9.1086","volume":"296","author":"A Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Pol\u00f3nia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296:1086\u201393.","journal-title":"JAMA"},{"key":"857_CR24","volume-title":"Manual de enfermedades infecciosas en Atenci\u00f3n Primaria","author":"C S\u00e1nchez-Hern\u00e1ndez","year":"2010","unstructured":"S\u00e1nchez-Hern\u00e1ndez C, Cots-Yago JM, Monedero-Mira MJ, Arranz-Izquierdo J, G\u00f3mez-Garc\u00eda M, Morat\u00f3-Agust\u00ed ML. Manual de enfermedades infecciosas en Atenci\u00f3n Primaria. 3\u00aa ed. Barcelona: Semfyc ediciones; 2010.","edition":"3\u00aa ed."},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/qshc.2006.021121","volume":"16","author":"S Coenen","year":"2007","unstructured":"Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, et al. European surveillance of antimicrobial consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007;16:440\u20135.","journal-title":"Qual Saf Health Care"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","volume":"66","author":"N Adriaenssens","year":"2011","unstructured":"Adriaenssens N, Coenen S, Versporten A, Muller A, Vankerckhoven V, Goossens H. European surveillance of antimicrobial consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66:vi71\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamainternmed.2013.14191","volume":"174","author":"D Meeker","year":"2014","unstructured":"Meeker D, Knight TK, Friedberg MW, Linder JA, Goldstein NJ, Fox CR. Nudging guideline-concordant antibiotic prescribing: A randomized clinical trial. JAMA Intern Med. 2014;174:425\u201331.","journal-title":"JAMA Intern Med"},{"key":"857_CR28","doi-asserted-by":"publisher","first-page":"e1001346","DOI":"10.1371\/journal.pmed.1001346","volume":"9","author":"C Weijer","year":"2012","unstructured":"Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, et al. The Ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Med. 2012;9:e1001346.","journal-title":"PLoS Med"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/0272989X11418372","volume":"32","author":"M Gomes","year":"2012","unstructured":"Gomes M, Ng ES, Grieve R, Nixon R, Carpenter J, Thompson SG. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Mak. 2012;32:350\u201361.","journal-title":"Med Decis Mak"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pmedr.2015.11.015","volume":"3","author":"A Brousselle","year":"2016","unstructured":"Brousselle A, Benmarhnia T, Benhadj L. What are the benefits and risks of using return on investment to defend public health programs? Prev Med Rep. 2016;3:135\u20138.","journal-title":"Prev Med Rep"},{"key":"857_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamainternmed.2013.1589","volume":"173","author":"R Gonzales","year":"2013","unstructured":"Gonzales R, Anderer T, McCulloch CE, Maselli JH, Bloom FJ Jr, Graf TR. A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med. 2013;173:267\u201373.","journal-title":"JAMA Intern Med"},{"key":"857_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dkv328","volume":"71","author":"AW Van der Velden","year":"2016","unstructured":"Van der Velden AW, Kuyvenhoven MM, Verheij TJ. Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: the ARTI4 randomized trial. J Antimicrob Chemother. 2016;71:257\u201363.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/fmb-2016-0010","volume":"11","author":"F Roque","year":"2016","unstructured":"Roque F, Teixeira-Rodrigues A, Breitenfeld L, Pi\u00f1eiro-Lamas M, Figueiras A, Herdeiro MT. Decreasing antibiotic use through a joint intervention targeting physicians and pharmacists. Future Microbiol. 2016;11:877\u201386.","journal-title":"Future Microbiol"},{"key":"857_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","volume":"315","author":"D Meeker","year":"2016","unstructured":"Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA. 2016;315:562\u201370.","journal-title":"JAMA"},{"key":"857_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/bmj.38182.591238.EB","volume":"329","author":"I Welschen","year":"2004","unstructured":"Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004;329:431.","journal-title":"BMJ"},{"key":"857_CR36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.aprim.2014.02.006","volume":"46","author":"C Llor","year":"2014","unstructured":"Llor C, Cots JM, Hern\u00e1ndez S, Ortega J, Arranz J, Monedero MJ, et al. Effectiveness of two types of intervention on antibiotic prescribing in respiratory tract infections in primary Care in Spain. Happy Audit study. Aten Primaria. 2014;46:492\u2013500.","journal-title":"Aten Primaria"},{"key":"857_CR37","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/jac\/dky137","volume":"73","author":"C Llor","year":"2018","unstructured":"Llor C, Bjerrum L, Molero JM, Moragas A, Gonz\u00e1lez L\u00f3pez-Valc\u00e1rcel B, Monedero MJ, et al. Long-term effect of a practice-based intervention (HAPPY AUDIT) aimed at reducing antibiotic prescribing in patients with respiratory tract infections. J Antimicrob Chemother. 2018;73:2215\u201322.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/qhc.12.3.215","volume":"12","author":"MA van Bokhoven","year":"2003","unstructured":"van Bokhoven MA, Kok G, van der Weijden T. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care. 2003;12:215\u201320.","journal-title":"Qual Saf Health Care"},{"key":"857_CR39","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1185\/03007995.2016.1154520","volume":"32","author":"A Teixeira Rodrigues","year":"2016","unstructured":"Teixeira Rodrigues A, Ferreira M, Pi\u00f1eiro-Lamas M, Falc\u00e3o A, Figueiras A, Herdeiro MT. Determinants of physician antibiotic prescribing behavior: a 3 year cohort study in Portugal. Curr Med Res Opin. 2016;32:949\u201357.","journal-title":"Curr Med Res Opin"},{"key":"857_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12879-015-1332-y","volume":"16","author":"A Teixeira Rodrigues","year":"2016","unstructured":"Teixeira Rodrigues A, Ferreira M, Roque F, Falc\u00e3o A, Ramalheira E, Figueiras A, Herdeiro MT. Physicians\u2019 attitudes and knowledge concerning antibiotic prescription and resistance: questionnaire development and reliability. BMC Infect Dis. 2016;16:7.","journal-title":"BMC Infect Dis"},{"key":"857_CR41","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1093\/jac\/dkz244","volume":"74","author":"A Teixeira Rodrigues","year":"2019","unstructured":"Teixeira Rodrigues A, Roque F, Pi\u00f1eiro-Lamas M, Falc\u00e3o A, Figueiras A, Herdeiro MT. Effectiveness of an intervention to improve antibiotic-prescribing behaviour in primary care: a controlled, interrupted time-series study. J Antimicrob Chemother. 2019;74:2788\u201396.","journal-title":"J Antimicrob Chemother"},{"key":"857_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1086\/591126","volume":"47","author":"N Shehab","year":"2008","unstructured":"Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47:735\u201343.","journal-title":"Clin Infect Dis"},{"key":"857_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12879-016-1990-4","volume":"16","author":"CI Michaelidis","year":"2016","unstructured":"Michaelidis CI, Fine MJ, Lin CJ, Linder JA, Nowalk MP, Shields RK, et al. The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis. BMC Infect Dis. 2016;16:655.","journal-title":"BMC Infect Dis"},{"key":"857_CR44","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1002\/sim.1858","volume":"23","author":"N Klar","year":"2004","unstructured":"Klar N, Darlington G. Methods for modelling change in cluster randomization trials. Statist Med. 2004;23:2341\u201357.","journal-title":"Statist Med"},{"key":"857_CR45","doi-asserted-by":"publisher","first-page":"j3064","DOI":"10.1136\/bmj.j3064","volume":"358","author":"K Hemming","year":"2017","unstructured":"Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M. How to design efficient cluster randomised trials. BMJ. 2017;358:j3064.","journal-title":"BMJ"},{"key":"857_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","volume":"67","author":"J McCambridge","year":"2014","unstructured":"McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67:267\u201377.","journal-title":"J Clin Epidemiol"},{"key":"857_CR47","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(05)66516-6","volume":"365","author":"KF Schulz","year":"2005","unstructured":"Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet. 2005;365:1657\u201361.","journal-title":"Lancet"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00857-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13756-020-00857-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00857-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T15:28:12Z","timestamp":1607354892000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00857-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00857-9","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"19 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Galician Ethics Committee (code number 2007\/107).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}